(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-Alpha-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrobromide (Technichal Grade)

CAS: 131086-18-5

Ref. TR-A630655

Produktinformation

• Name: (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-Alpha-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrobromide (Technichal Grade)
• Synonyme: (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrobromide (Technichal Grade)
• Marke: TRC

Beschreibung

Applications (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrobromide is an impurity of Doxorubicin (D558000), an antineoplastic agent.
References Di Marco, A., et al.: Cancer Chemother. Rep., (part 1), 53, 33 (1969); Mihich, E. and Ehrke, M.J.: Transplant. Proc., 16, 499 (1984);

Chemische Eigenschaften

• Molekulargewicht: 761.45
• Formel: C₃₁H₃₈BrNO₁₁·HBr
• Farbe/Form: Neat
• InChl: InChI=1S/C31H38BrNO11.BrH/c1-5-41-31(13-32,42-6-2)30(39)11-16-22(19(12-30)44-20-10-17(33)25(34)14(3)43-20)29(38)24-23(27(16)36)26(35)15-8-7-9-18(40-4)21(15)28(24)37;/h7-9,14,17,19-20,25,34,36,38-39H,5-6,10-13,33H2,1-4H3;1H/t14-,17-,19-,20-,25+,30-;/m0./s1
• InChI Key: InChIKey=LVCKYJWASFULNV-UOJYQOEASA-N
• SMILES: Br.CCOC(CBr)(OCC)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@@H](N)[C@@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O